| Market Cap | ₹49Cr |
| ROE | 2.42% |
| P/E Ratio(TTM) | 78.00 |
| EPS(TTM) | 0.44 |
| P/B Ratio | 1.84 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.40 |
| Book Value | 18.63 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Bacil Pharma Limited |
| BSE Symbol | 524516 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.16 | ||
| Neuland Laboratories | NA (0.00%) | 81.90 | ||
| Jubilant Pharmova | NA (0.00%) | 36.26 | ||
| Acutaas Chemicals | NA (0.00%) | 61.43 |